Objective-Although nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) is reportedly essential for phagocyte host defenses, it has been found to aggravate atherosclerosis in apolipoprotein E (Apoe)-null mice through excess production of superoxide. We therefore assessed the role of NOX2 in an experimental model of abdominal aortic aneurysm (AAA) and assessed the mechanism of NOX2 action in AAA. Approach and Results-AAA was induced in low-density lipoprotein receptor-null (Ldlr -/-) mice by infusing angiotensin II.
A bdominal aortic aneurysm (AAA) is a major cause of cardiovascular deaths and the tenth leading cause of death in men >65 years of age in Western countries. 1 The prevalence of AAA in the elderly has been estimated at 8.8%, 2 with a mortality rate of 80% after AAA rupture. 3 Although AAA rupture is life threatening, molecular targets for this disease have not yet been identified. AAA is often treated surgically, with artificial vessels or stent grafts. 4 To reduce surgical exposure and its accompanying side effects, various candidate molecules targeting AAA, including nicotinamide adenine dinucleotide phosphate oxidase (NOX) isozymes, are currently undergoing experimental trials.
NOX isozymes, which are composed of catalytic subunits (eg, NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1, and DUOX2) and subcomponents (eg, p22 phox , p47 phox , p67 phox , Rac1, and Rac2), stimulate the production of reactive oxygen species, including superoxide and hydrogen peroxide. 5 After the cloning of the gene that encodes NOX2 (Cybb), 6, 7 the role of NOX systems could be investigated in phagocytic and host defense functions, including the respiratory burst. 8 Nonphagocyte NOX homologs were identified subsequently and characterized functionally in other cell types, including cells that make up vascular components. 9 NOX2 expression was observed recently in vascular endothelial and macrophage-derived foam cells in atheromas of apolipoprotein E (Apoe)-null mice, with a deficiency in Nox2 suppressing atherosclerotic development in mice. 10 In addition, suppression of Nox1 as well as the common cytosolic subcomponent p47 phox inhibited AAA pathogenesis in mouse models. 11, 12 Taken together, these findings indicated that excess NOX activation augments atherosclerosis and AAA.
A recent meta-analysis showed that antioxidants, such as vitamin E and β-carotene, failed to prevent the development of atherosclerosis and related cardiovascular events, 13 suggesting that antioxidants may be clinically ineffective in patients with atherosclerotic diseases. More specific clinical approaches, targeting certain molecules, may be more promising because targeting redox-related Nox genes suppressed atherosclerotic disease in mice. 10 However, the heterogeneity of biological redox systems complicates the understanding of the molecular basis of these diseases. For example, NOX4, which stimulates hydrogen peroxide production in vascular endothelial cells, has been reported to play an angiogenic and anti-inflammatory role under ischemic and inflammatory conditions, 14 indicating that hydrogen peroxide may exhibit vasoprotective effects in certain situations. Moreover, genetic defects in phagocytic NOX systems have been found to induce chronic granulomatous disease, with most patients with chronic granulomatous disease experiencing systemic sterile hyperinflammation. 5 Indeed, myeloid-specific deficiency of p47 phox was shown sufficient for aggravating zymosan-induced lung inflammation, 15 suggesting that NOX systems in phagocytes may possess anti-inflammatory-like properties.
The roles of NOX systems in specific diseases, including the pathophysiological significance of NOX isozymes, except for NOX1 and p47 phox , in AAA, remain unclear. We therefore sought to characterize the roles of NOX2 in AAA using a gene-targeting approach.
Materials and Methods
An expanded materials and methods section is available in the onlineonly Supplement.
Results

Loss of Nox2 Exacerbates Angiotensin II-Induced AAA in Mice
AAA was induced in high-cholesterol diet-fed Nox2 +/y /lowdensity lipoprotein receptor-deficient (Ldlr -/-) mice by infusing angiotensin II (AngII). Real-time reverse transcriptase polymerase chain reaction showed high levels of Nox2 mRNA expression in the ascending and abdominal aorta after 28 days of AngII infusion ( Figure 1A) . In contrast, the levels of Nox1 and Nox4 mRNA were not altered significantly. Immunohistochemical analysis showed the presence of NOX2positive cells in the adventitia of AAA lesions in Nox2 +/y / Ldlr -/-, but not in Nox2 -/y /Ldlr -/mice ( Figure 1B ; Figure I in the online-only Data Supplement), with these cells corresponding to monocyte/macrophage antigen-2 (MOMA-2)-positive macrophages ( Figure 1C ). In contrast, NOX2 expression was negligible in vascular endothelial cells and smooth muscle cells.
Next, Nox2 +/y /Ldlr -/and Nox2 -/y /Ldlr -/mice were examined for AAA. The maximal diameter and wet weight of AAAs were significantly greater in Nox2 -/y /Ldlr -/than in Nox2 +/y /Ldlr -/mice ( ( Figure 2D ), and immunohistochemistry showed enrichment of IL-1β in MOMA-2-positive macrophages present in the adventitial regions of Nox2 -/y /Ldlr -/mice ( Figure 2E ; Figure V in the online-only Data Supplement). Immunohistochemical assays also showed that recruitment of MOMA-2-positive macrophages in the adventitial regions was equivalent in Nox2 +/y /Ldlr -/and Nox2 -/y /Ldlr -/mice ( Figure 2F ), and that the abundance of M1 macrophages (inducible nitric oxide synthase + MOMA-2 + cells) in the adventitial regions was further potentiated by Nox2 deficiency ( Figure 2G ). Real-time reverse transcriptase polymerase chain reaction showed that basic fibroblast growth factor (Fgf2) and type IV collagen (Col4) mRNA expression declined as a result of Nox2 deficiency, whereas the expression of transforming growth factor-β (Tgfb1), fibronectin (Fn1), and type I collagen (Col1a1) mRNAs remained unchanged ( Figure 3A ). Immunohistochemical staining revealed collagen IV localization in the adventitial regions of AAA in Nox2 +/y /Ldlr -/mice ( Figure 3B ; Figure VI in the online-only Data Supplement), but not in mice with a Nox2 deficiency. Dihydroethidium staining showed that oxidative stress in AAA lesions was much greater in Nox2 +/y /Ldlr -/than in Nox2 -/y /Ldlr -/mice ( Figure 3C ; Figure VII in the online-only Data Supplement). This was matched with higher superoxide levels in Nox2 +/y /Ldlr -/-AAA lesions comparing with those in Nox2 -/y /Ldlr -/lesions ( Figure 3D ). Consistently, immunohistochemistry showed that Nox2 deficiency markedly diminished nitrotyrosine staining, indicating reductions in oxidative damage in AAA lesions by Nox2 deficiency ( Figure 3E ; Figure VIII in the online-only Data Supplement). Interestingly, in situ zymography indicated that gelatinase activity in adventitial regions was elevated by Nox2 deficiency, whereas that in medial lesions was not substantially influenced ( Figure 3F ; Figure IX in the online-only Data Supplement). Similarly, the levels of expression of matrix metalloproteinase 2 (Mmp2) and tissue inhibitor of MMP (Timp)1, Timp2, and Timp3 mRNA were equivalent in AAA lesions of Nox2 +/y /Ldlr -/and Nox2 -/y /Ldlr -/mice. In contrast, Nox2 deficiency enhanced the expression of Mmp9 and Mmp12 mRNA ( Figure 3G ).
Contribution of IL-1β to exacerbation of AAA in Nox2deficient mice was assessed. The AngII-infused Nox2-deficient mice that received repeated administration of nonimmune control IgG (cont IgG) or neutralizing antibody against IL-1β (anti-IL-1β) were compared ( Figure 4A ). Although 29% of IgG control mice (2/7) died during AngII infusion, all of mice that received neutralizing antibody survived (5/5). Furthermore, neutralization of IL-1β significantly declined abdominal aortic diameter in Nox2-deficient mice ( Figure 4B ). Systolic blood pressure and body weight in the mice that received control IgG and IL-1β-neutralizing antibody were comparable (Figure X in the online-only Data Supplement).
The contribution of bone marrow NOX2 to AAA pathogenesis was assessed by performing bone marrow transplantation experiments. Polymerase chain reaction-based genotyping validated bone marrow chimerism in recipient mice (Nox2 +/y / Ldlr -/-) transplanted with Nox2 -/y /Ldlr -/bone marrow cells (chimeric mice), but not with Nox2 +/y /Ldlr -/bone marrow cells (nonchimeric mice; Figure 5A ). Because both Nox2 wild-type and knockout alleles were detected in AAA lesions in the chimeric mice, the Nox2-deficient bone marrow cells were likely recruited into AAA lesions originally composed of Nox2-expressing resident cells. After infusion of AngII, Nox2chimeric mice showed a higher rate of rupture-associated mortality than nonchimeric mice ( Figure 5B ). Isolated abdominal aortae from survivors (8/19) showed significant expansion of AAA lesions compared with nonchimeric survivors (8/10; Figure 5C ). The levels of expression of IL-1β (Il1b) mRNAs were higher in AAA lesions of chimeric than nonchimeric mice ( Figure 5D ), although their systolic blood pressure was equivalent ( Figure XI in the online-only Data Supplement).
Nox2 Deficiency Enhances IL-1β Secretion From Interferon-γ-Primed M1 Macrophages
Murine bone marrow cells differentiate into classically (M1) and alternatively (M2) activated bone marrow-derived macrophages (BMMs) in response to stimulation with interferon (IFN)-γ and IL-4, respectively. Nox2 mRNA was induced by IFN-γ, but not by IL-4, in Nox2 +/y /Ldlr -/-BMMs, but was abolished in Nox2 -/y /Ldlr -/-BMMs ( Figure 6A ). Nox1 and Nox4 expression in BMMs was originally negligible and compensatory changes were not induced by Nox2 deficiency. Dichlorofluorescein assays indicated that the intracellular oxidative stress in Nox2 +/y / Ldlr -/-BMMs, induced by IL-4 or IFN-γ, was inhibited by Nox2 deficiency or the addition of the free radical scavenger N-acetylcysteine ( Figure 6B) . Similarly, the induction of H 2 O 2 by IL-4 or IFN-γ was abolished by Nox2 deficiency ( Figure 6C ). IFN-γ-primed Nox2 +/y /Ldlr -/-BMMs showed induction of the M1 markers inducible nitric oxide synthase (Nos2), IL-1β (Il1b), and tumor necrosis factor (TNF)-α (Tnf), with iNOS and IL-1β expression, but not TNF-α expression, being robustly stimulated by Nox2 deficiency ( Figure 6D ; Figure XIIA in the online-only Data Supplement), resulting in IL-1β secretion ( Figure 6E ). Overexpression of IL-1β by Nox2 deficiency is similarly detectable in TNF-α-stimulated or IFN-γ-stimulated peritoneal macrophages, but not in neutrophils ( Figure 6F ). IFN-γ treatment stimulated signal transducers and activators of transcription 1 (Stat1; Figure 6G ) and inflammasome-related genes (Casp1, Nlrp1b, and Nlrp3; Figure XIIB in the onlineonly Data Supplement) in BMMs without altering IFN-γ receptor mRNA expression levels (Ifngr1 and Ifngr2; Figure XIIC in the online-only Data Supplement). This induction of Stat1, but not of inflammasome-related genes, was enhanced by Nox2 deficiency. Treatment of Nox2 +/y /Ldlr -/or Nox2 -/y /Ldlr -/-BMMs with AG490, an inhibitor of Janus kinase/STAT signals, 16 abolished IL-1β upregulation by IFN-γ ( Figure 6H ). IL-4-primed Nox2 +/y /Ldlr -/-BMMs induced the M2 marker arginase-1 (Arg1), the expression of which was accelerated by Nox2 deficiency, although its rate of increase was not >2-fold ( Figure 6I ). Nox2 deficiency constitutively upregulated Mmp9 mRNA expression ( Figure 6I ), whereas the expression levels of Mmp12 and transforming growth factor-β (Tgfb1) mRNA in Nox2 +/y /Ldlr -/and Nox2 -/y /Ldlr -/-BMMs were similar, even in response to cytokines ( Figure XIID and XIIE in the online-only Data Supplement). The results of gelatin zymography were consistent with the Mmp9 mRNA levels ( Figure 6J ). Induction of MMP9 by Nox2 deficiency was suppressed by BAY11-7082, an inhibitor of nuclear factor-κB (NF-κB) signals, 17 in the presence or absence of IFN-γ ( Figure 6K ). Expression levels of IκBs (Nfkbia, Nfkbib, and Nfkbie) in BMMs were declined by the Nox2 deficiency even in the absence of cytokine stimulus (Figure 6L ).
Discussion
The present study reveals that Nox2 deficiency results in harmful outcomes in an animal model of AAA. Because an absence of Nox2 has been found to upregulate proinflammatory responses (eg, production of IL-1β, IL-6 , and TNF-α), thereby aggravating arthritis 18 and systemic inflammatory response syndrome, 19 as well as chronic granulomatous disease, 15 Nox2 may possess anti-inflammatory-like effects even in inflammatory vascular diseases. Consistent with previous findings, 20 we found that NOX2 contributes to reactive oxygen species generation in macrophages, although we also found that a Nox2 deficiency in macrophages potentiated the secretion of IL-1β and MMP9. IL-1β and MMPs was similarly upregulated in aggravated AAA lesions of Nox2-null mice, suggesting that a deficiency in Nox2 markedly disturbs proinflammatory cascades in macrophages present in AAA lesions.
IL-1β is normally synthesized by intracellular transcriptional systems as an immature, biologically inactive pro-IL-1β. This molecule is proteolytically converted to mature IL-1β by caspase-1-based inflammasome systems. 21 A deficiency in Nox2 or p47 phox was found to significantly upregulate lipopolysaccharide (LPS)-induced IL-1β expression in lung, accompanied by the activation of activator protein-1 and NF-κB transcriptional systems. 22 Moreover, a loss-of-function mutation in p47 phox caused inflammatory skin lesions in mice concomitant with the upregulation of IL-1β, with both suppressed by the genetic reintroduction of wild-type p47 phox . 23 Monocytes from chronic granulomatous disease patients lacking p47 phox have been found to produce higher amounts of IL-1β in response to LPS than monocytes from healthy subjects, an increase likely because of the upregulation of caspase-1-based inflammasomes. 24 Thus, a lack of NOX systems enhances IL-1β production in monocytes/ macrophages. Current results further showed that aggravation of AAA in Nox2-deficient mice, which is similarly inducible by myeloid-specific deficiency of Nox2, was resolved by systemic neutralization of IL-1β. It is noteworthy that NOX2 is expressed mainly in macrophages and neutrophils among the myeloid-derived cells, 5 and that myeloid-specific suppression of Nox2 significantly upregulated IL-1β expression in AAA lesions; thus, it is likely that IL-1β derived from macrophages and neutrophils is responsible for accelerating AAA in Nox2deficient mice. Our results consistently showed that IFNγ-stimulated or TNF-α-stimulated peritoneal macrophages as well as IFN-γ-stimulated BMMs exhibited excess induction of IL-1β under the Nox2-null conditions, and the latter cells displayed acceleration of STAT1 mRNAs, but not of mRNAs encoded by inflammasome-related genes, such as Casp1 and Nlrp1a (Figure X in the online-only Data Supplement). Because JAK/STAT inhibitor abolished IL-1β induction in IFN-γ-stimulated BMMs, even in the absence of Nox2, excess production of IL-1β by Nox2-null BMMs may be attributed to STAT1 overexpression. Consistently, in cells stimulated with IFN-γ, most pro-IL-1β seems to be transcribed through the JAK/STAT1 signaling pathway. 25 In contrast, unlikely Figure 6 . Nicotinamide adenine dinucleotide phosphate oxidase 2 (Nox2) deficiency converts M1 macrophages to an overactive state. macrophage colony-stimulating factor (50 ng/mL)-differentiated bone marrow-derived macrophages (BMMs) were stimulated with interferon (IFN)-γ (10 ng/mL) and interleukin (IL)-4 (10 ng/mL) for 16 hours, to skew them toward M1 and M2 subsets, respectively. Peritoneal macrophages and neutrophils were stimulated with IFN-γ (50 ng/mL) and tumor necrosis factor (TNF)-α (10 ng/mL) for 16 hours. to macrophages, TNF-α-induced or IFN-γ-induced IL-1β expression was equivalent between the Nox2-wild-type and Nox2-deficient neutrophils. This is matched with previous report suggesting that Nox2 deficiency did not enhance but rather declined inflammasome-derived IL-1β in neutrophils. 26 Taken together, excessive IL-1β derived from overactivated macrophages may be primary cue for exacerbation of AAA in Nox2-deficient mice. These deleterious roles of IL-1β in AAA are consistent with earlier results showing that the suppression of IL-1β or its receptor expression ameliorated AAA in mouse models. 27 Macrophages in inflamed lesions originate from bone marrow cells. 28 After emigration from bone marrow, monocytes patrol systemic blood vessels and are recruited into inflamed lesions by gradients of inflammatory cytokines and chemokines (eg, chemokine [C-C motif] ligand2). Mouse monocytes normally differentiate into M1-and M2-activated macrophages in response to T helper 1 (eg, IFN-γ and Toll-like receptor ligands) and T helper 2 (eg, IL-4 and IL-13) cytokines, respectively. Transplantation of aortic allografts into IFN-γ receptor null mice led to the formation of aneurysms, 29 which may be because of excess secretion of MMP12 by IL-4-primed macrophages. Indeed, targeting of IL-4 signals reduced aneurysm formation. Conversely, the prevalence of M1 macrophages was found to be elevated in ruptured, but not intact, human cerebral aneurysms, 30 suggesting that an imbalance between M1 and M2 macrophages can trigger extracellular matrix degradation and subsequent instability of AAA. We found that Nox2 deficiency promoted IFN-γ-primed conversion of BMMs to M1 macrophages, as well as potentiating the predominance of M1 macrophages in AAA lesions, suggesting that macrophages may be polarized preferentially into the M1 subset even in AAA lesions. Because most macrophages in AAA lesions express M1 markers, it was not surprising that a Nox2 deficiency contributes to the exacerbation of AAA, by skewing toward M1 macrophages.
Although MMPs play a key role in maintaining physiological extracellular matrix turnover, excess MMP secretion during the inflammatory process has been found to augment AAA. In particular, macrophage-derived and vascular cell-derived MMP9 and MMP12 are considered major exacerbators of AAA, 31, 32 because they break down vascular structures, including the elastic lamellae and basement membrane. We found that the expression levels of MMP9 and MMP12, but not of MMP2, in AAA lesions, were elevated by Nox2 deficiency. Moreover, MMP9 in Nox2-deficient BMMs seemed to be constitutively upregulated via NF-κB signals. Our in situ zymography data suggested that Nox2 deficiency potentiated MMP activity in adventitial, but not medial, regions in AAAs. Because Nox2 deficiency decreased the deposition of type IV collagen in AAA lesions, deficiencyinduced excess MMP expression likely prevents type IV deposition, particularly in adventitial regions. Reducing the content of specific extracellular matrix may reduce vascular stiffness, thereby accelerating aortic dissection.
The results presented here highlight the potential concerns of targeting Nox2 to treat AAA. Although earlier study displayed that inhibition of Nox2 using small interfering RNA suppressed proinflammatory MMPs on macrophages, 33 our present data show that Nox2 deficiency by gene targeting leads macrophages to hyperinflammatory phenotype. It is difficult to determine the mechanisms by which such opposite phenotypes arise; nevertheless, unexpected occurrence of hyperinflammation by NOX2 intervention is worthy to be attended. It is important to carefully monitor such hyperinflammatory phenotype when NOX2 intervention is conducted in future clinical study. This probably suggests the importance of choosing an appropriate NOX subtype(s) as a molecular target for AAA. Because Nox1 deficiency has been reported to ameliorate AAA, targeting this molecule may be successful in treating AAA. However, additional studies are needed to assess the impact of other vascular NOX subtypes on AAA.
Nicotinamide adenine dinucleotide phosphate oxidase (NOX) systems are considered candidate molecular targets in the treatment of chronic inflammatory diseases, including abdominal aortic aneurysms because NOX-derived oxidative stress has been found to contribute to most inflammatory disorders. However, recent advances in gene-targeting techniques have shown that some NOX isozymes (eg, NOX4) exert vasoprotective roles in certain situations. Using a murine model of abdominal aortic aneurysm, we showed that Nox2 deficiency augmented abdominal aortic aneurysm through the excess production of interleukin-1β and matrix metalloproteinase-9 by M1 macrophages. In addition, our findings suggest that the macrophage overactivation by Nox2 deficiency may be manifested mechanistically by upregulation of signal transducers and activators of transcription 1 and nuclear factor-κB signals. Accordingly, it is concerned whether substantial and prolonged NOX2 intervention induces hyperinflammation in macrophages, although the mechanisms by which such hyperinflammation is triggered under the Nox2-null conditions remain elusive. Understanding the distinct roles of NOX subtypes is critical in targeting biological redox systems in patients with aneurysmal diseases.
Significance
